Skip Nav Destination
Issues
Review
Research Articles
Tumor Necrosis Factor a-11 and DR15-DQ6 (B*0602) Haplotype Increase the Risk for Cervical Intraepithelial Neoplasia in Human Papillomavirus 16 Seropositive Women in Northern Sweden1
Mehran Ghaderi; Liene Nikitina; Christopher S. Peacock; Peter Hjelmström; Goran Hallmans; Fredrik Wiklund; Per Lenner; Jennifer M. Blackwell; Joakim Dillner; Carani B. Sanjeevi
Randomized Trial of Fenretinide in Superficial Bladder Cancer Using DNA Flow Cytometry as an Intermediate End Point1
Andrea Decensi; Rosalba Torrisi; Silvia Bruno; Massimo Costantini; Antonio Curotto; Guido Nicolò; Bruno Malcangi; Laura Baglietto; Gian Paolo Bruttini; Beatrice Gatteschi; Gabriella Rondanina; Marco Varaldo; Marjorie Perloff; Winfred F. Malone; Paolo Bruzzi
Novel Translational Model for Breast Cancer Chemoprevention Study: Accrual to a Presurgical Intervention with Tamoxifen and N-[4-Hydroxyphenyl] Retinamide1
Eva Singletary; Ron Lieberman; Nealy Atkinson; Nour Sneige; Ayse Sahin; Susanne Tolley; Mary Colchin; Therese Bevers; Carol Stelling; Bruno Fornage; Herbert Fritsche; Walter Hittelman; Gary Kelloff; Scott M. Lippman
Short Communications
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.